Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

Count me dazed and confused. I'm baffled by how this is unfolding, to wit:

They raise $170M + just over 2 years ago at $6.75, shortly after the stock hit $10 +.

Management exhibits nothing short of excellence/brilliance in execution as they add VOS for DES, VCS for FSGS, while exceeding expectations for their P3 trial of VCS for LN.

The reward to shareholders for this outsized management performance? Essentially zilch.

They recently closed out their ATM at a lousy $6.55, cheaper than their earlier raise, despite tremendous forward strides in development.

Their 10 year use patent extension for Voclosporin is just one example of the impressive things Aurina has accomplished.

I'm really surprised we're not at $10+ right now. When does this potential sleeping giant wake up for real?

Beats the hell out of me. Hallelujah anyway!